This subteam advances computational methods to optimize precision medicine strategies with a large-scale of data to give the right patient the right treatment at the right time. Some topics are patient enrichment, biomarker identification and individualized treatment rules.
Gina D'Angelo (Astrazeneca) and Lu Tang (University of Pittsburgh)
TBD